Emerald Acquisition Ltd. acquired a new stake in shares of AptarGroup Inc. (NYSE:ATR) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 48,761 shares of the company’s stock, valued at approximately $3,858,000. Emerald Acquisition Ltd. owned about 0.08% of AptarGroup at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in ATR. C M Bidwell & Associates Ltd. increased its stake in AptarGroup by 16.9% in the first quarter. C M Bidwell & Associates Ltd. now owns 1,555 shares of the company’s stock valued at $122,000 after buying an additional 225 shares during the last quarter. Independent Portfolio Consultants Inc. increased its stake in AptarGroup by 8.6% in the second quarter. Independent Portfolio Consultants Inc. now owns 2,020 shares of the company’s stock valued at $160,000 after buying an additional 160 shares during the last quarter. Smith Salley & Associates bought a new stake in AptarGroup during the second quarter valued at approximately $210,000. Fiduciary Management Inc. WI bought a new stake in AptarGroup during the first quarter valued at approximately $212,000. Finally, Magnetar Financial LLC bought a new stake in AptarGroup during the first quarter valued at approximately $232,000. 88.33% of the stock is owned by institutional investors.

AptarGroup Inc. (NYSE:ATR) traded down 0.38% on Wednesday, reaching $78.42. The company’s stock had a trading volume of 413,240 shares. AptarGroup Inc. has a 12 month low of $63.62 and a 12 month high of $81.50. The firm has a market cap of $4.94 billion, a price-to-earnings ratio of 25.46 and a beta of 0.93. The firm has a 50 day moving average of $77.44 and a 200 day moving average of $77.67.

AptarGroup (NYSE:ATR) last announced its earnings results on Thursday, July 28th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.01. The company had revenue of $620 million for the quarter, compared to analysts’ expectations of $621.52 million. AptarGroup had a return on equity of 16.67% and a net margin of 8.54%. AptarGroup’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.82 earnings per share. Analysts anticipate that AptarGroup Inc. will post $3.18 earnings per share for the current year.

A number of research firms recently weighed in on ATR. Robert W. Baird increased their price target on AptarGroup from $80.00 to $84.00 and gave the company a “neutral” rating in a research note on Friday, September 9th. BMO Capital Markets restated a “hold” rating on shares of AptarGroup in a research note on Friday, September 9th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $76.00.

In related news, CFO Robert Kuhn sold 3,000 shares of AptarGroup stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $78.59, for a total transaction of $235,770.00. Following the transaction, the chief financial officer now owns 15,050 shares of the company’s stock, valued at $1,182,779.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director King W. Harris sold 13,100 shares of AptarGroup stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $76.62, for a total value of $1,003,722.00. Following the transaction, the director now directly owns 195,509 shares in the company, valued at approximately $14,979,899.58. The disclosure for this sale can be found here. Corporate insiders own 5.50% of the company’s stock.

AptarGroup Company Profile

AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located in North America, Europe, Asia and South America.

5 Day Chart for NYSE:ATR

Want to see what other hedge funds are holding ATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AptarGroup Inc. (NYSE:ATR).

Receive News & Ratings for AptarGroup Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup Inc. and related companies with MarketBeat.com's FREE daily email newsletter.